BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37864854)

  • 1. Isolated vaginal recurrence in women with stage I endometrial cancer.
    Rios-Doria E; Cun HT; Filippova OT; Mueller JJ; Alektiar KM; Ellenson LH; Makker V; Lakhman Y; Leitao MM; Jhingran A; Soliman PT; Abu-Rustum NR
    Gynecol Oncol; 2023 Dec; 179():9-15. PubMed ID: 37864854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-institutional outcomes of adjuvant brachytherapy for Stage I endometrial cancer-Are outcomes consistent with randomized studies?
    Dohopolski MJ; Horne ZD; Gebhardt BJ; Glaser SM; Edwards RP; Kelley JL; Comerci JT; Olawaiye AB; Courtney-Brooks M; Berger JL; Sukumvanich P; Beriwal S
    Brachytherapy; 2018; 17(3):564-570. PubMed ID: 29426745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of surgical approach on risk of recurrence after vaginal brachytherapy in early-stage high-intermediate risk endometrial cancer.
    Philp L; Tannenbaum S; Haber H; Saini A; Laurent JS; James K; Feltmate CM; Russo AL; Growdon WB
    Gynecol Oncol; 2021 Feb; 160(2):389-395. PubMed ID: 33358198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local recurrence in high-risk node-negative stage I endometrial carcinoma treated with postoperative vaginal vault brachytherapy.
    Ng TY; Perrin LC; Nicklin JL; Cheuk R; Crandon AJ
    Gynecol Oncol; 2000 Dec; 79(3):490-4. PubMed ID: 11104626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of vaginal brachytherapy in the treatment of surgical stage I papillary serous or clear cell endometrial cancer.
    Barney BM; Petersen IA; Mariani A; Dowdy SC; Bakkum-Gamez JN; Haddock MG
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):109-15. PubMed ID: 22543202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of vaginal recurrences in endometrial carcinoma by high-dose-rate brachytherapy.
    Sorbe B; Söderström K
    Anticancer Res; 2013 Jan; 33(1):241-7. PubMed ID: 23267151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes in international federation of gynecology and obstetrics stage IA endometrial cancer with myometrial invasion treated with or without postoperative vaginal brachytherapy.
    Diavolitsis V; Rademaker A; Lurain J; Hoekstra A; Strauss J; Small W
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):415-9. PubMed ID: 22365625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant carboplatin, paclitaxel, and vaginal cuff brachytherapy for stage III endometrial cancer: analysis of outcomes and patterns of recurrence based on pathologic characteristics.
    Young MR; Higgins SA; Ratner E; Yu JB; Mani S; Silasi DA; Azodi M; Rutherford T; Schwartz PE; Damast S
    Int J Gynecol Cancer; 2015 Mar; 25(3):431-9. PubMed ID: 25621409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose adjuvant vaginal cylinder brachytherapy for early-stage non-endometrioid endometrial cancer: recurrence risk and survival outcomes.
    Smart A; Buscariollo D; Alban G; Buzurovic I; Cheng T; Pretz J; Krechmer B; King M; Lee L
    Int J Gynecol Cancer; 2020 Dec; 30(12):1908-1914. PubMed ID: 32655012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endometrial carcinoma.
    Horowitz NS; Peters WA; Smith MR; Drescher CW; Atwood M; Mate TP
    Obstet Gynecol; 2002 Feb; 99(2):235-40. PubMed ID: 11814503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy.
    Hochreiter A; Kelly JR; Young MR; Litkouhi B; Black JD; Stromberger C; Higgins S; Schwartz PE; Damast S
    Int J Gynecol Cancer; 2020 Jan; 30(1):48-55. PubMed ID: 31722964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial.
    Nout RA; Smit VT; Putter H; Jürgenliemk-Schulz IM; Jobsen JJ; Lutgens LC; van der Steen-Banasik EM; Mens JW; Slot A; Kroese MC; van Bunningen BN; Ansink AC; van Putten WL; Creutzberg CL;
    Lancet; 2010 Mar; 375(9717):816-23. PubMed ID: 20206777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-institutional Analysis of Vaginal Brachytherapy Alone for Women With Stage II Endometrial Carcinoma.
    Harkenrider MM; Martin B; Nieto K; Small C; Aref I; Bergman D; Chundury A; Elshaikh MA; Gaffney D; Jhingran A; Lee L; Paydar I; Ra K; Schwarz J; Thorpe C; Viswanathan AN; Small W
    Int J Radiat Oncol Biol Phys; 2018 Aug; 101(5):1069-1077. PubMed ID: 29885996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of adjuvant vaginal brachytherapy in women with Stage II uterine endometrioid carcinoma: Results of a National Cancer Database analysis.
    Lee JK; Ghanem AI; Modh A; Burmeister C; Mahmoud O; Maxwell GL; Elshaikh MA
    Brachytherapy; 2018; 17(2):319-325. PubMed ID: 29174935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaginal brachytherapy alone for patients with Stage II endometrial cancer with inner half cervical stromal invasion.
    Barnes EA; Parra-Herran C; Martell K; Barbera L; Taggar A; Leung E
    Brachytherapy; 2019; 18(5):606-611. PubMed ID: 31200993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma--a prospective randomized study.
    Sorbe B; Horvath G; Andersson H; Boman K; Lundgren C; Pettersson B
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1249-55. PubMed ID: 21676554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Outcome of Exclusively Radiographer-led Delivery of Postoperative Vaginal Vault Brachytherapy for Endometrial Cancer - The Addenbrooke's Experience.
    Buckley H; Bradshaw K; Gregory D; Prewett S; Tan LT
    Clin Oncol (R Coll Radiol); 2019 Dec; 31(12):844-849. PubMed ID: 31307862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A population-based study of outcomes in adjuvant radiotherapy for stage II endometrial carcinoma.
    Moldovan N; Lambert P; Ong A; Altman AD
    Int J Gynecol Cancer; 2022 Jun; ():. PubMed ID: 35732352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrences and toxicity after adjuvant vaginal brachytherapy in Stage I-II endometrial cancer: A monoinstitutional experience.
    Perrucci E; Lancellotta V; Bini V; Zucchetti C; Mariucci C; Montesi G; Saccia S; Palumbo I; Aristei C
    Brachytherapy; 2016; 15(2):177-84. PubMed ID: 26727332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of vaginal cuff brachytherapy in endometrial cancer.
    Harkenrider MM; Block AM; Siddiqui ZA; Small W
    Gynecol Oncol; 2015 Feb; 136(2):365-72. PubMed ID: 25555710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.